CS DIAGNOSTICS CORP. financial data

Symbol
CSDX on OTC
Location
Neuss, Germany
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 137,340,200 shares
Common Stock, Shares, Outstanding 137,340,200 shares
Common Stock, Value, Issued $1,373 USD
Weighted Average Number of Shares Outstanding, Basic 137,430,200 shares 5.9%
Weighted Average Number of Shares Outstanding, Diluted 137,430,200 shares 5.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $23,050 USD 189%
Research and Development Expense $0 USD
General and Administrative Expense $70 USD 0%
Operating Income (Loss) $182 USD -134%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current $31,013 USD
Assets $499,431,013 USD
Accounts Payable, Current $1,609 USD
Liabilities $1,609 USD
Retained Earnings (Accumulated Deficit) $4,735,847 USD
Stockholders' Equity Attributable to Parent $499,429,404 USD
Liabilities and Equity $499,431,013 USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 250,000,000 shares
Common Stock, Shares, Issued 137,340,200 shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $13 USD -100%
Additional Paid in Capital $504,161,838 USD